OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leveraging Chinese Hamster Ovary (CHO) cells presents a critical platform for the development of therapeutic monoclonal antibodies. Enhancing Mammalian Cell this process is essential to achieve high yields and quality antibodies. A variety of strategies can be implemented to enhance antibody production in CHO cells.